NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding NKGen Biotech, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 3 | 0 | −3 |
| Shares | 892.4K | 0 | −892.4K (−100.0%) |
| Value | $160.8K | $0 | −$160.8K (−100.0%) |
New holders (0)
Institutions that held NKGen Biotech, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (3)
Institutions that held NKGen Biotech, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Diametric Capital, LP | 518,134 | $93.3K |
| University of Chicago | 325,000 | $58.5K |
| Flow Traders U.S. LLC | 49,220 | $9.00K |